Toxoplasma gondii Seropositivity in Chemotherapy- Treated Cancer Patients in Sulaimani Province, Iraq
Academic Journal of International University of Erbil · 25.05.2026
DOI: 10.63841/iue3261100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Journal of International University of Erbil, online erschienen am 25.04.2026. Verfasst von Drakhshan Mahmood Mohammed und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Toxoplasma gondii (T. gondii) is a widespread intracellular parasite that infects humans and other warm-blooded animals. While usually harmless in heathy people, it can cause serious illness in those with weakened immune system. Cancer patients undergoing chemotherapy are especially at risk due to immune suppression and increase their susceptibility to infections like toxoplasmosis. A case- control study with 110 blood samples collected at Hiwa hospital, Sulaimani from cancer patients undergoing chemotherapy (n=76), and normal individual as controls from Sulaimani public health laboratory (n=34). Serum was separated and stored at (- 40˚C). Anti-T. gondii antibodies (IgG & IgM) were detected using the Roch Cobas® e411 automated electrochemiluminescence immunoassay. A total of 110 individuals were evaluated, T. gondii IgG- antibodies were detected in (42.7%), with higher seropositivity among cancer patients (46.1%) compared to control group (35.3%) (p= 0.292). IgM- antibodies were found only in (5.9%) controls and absent in cancer patients. Among IgG- positive cancer patients, 46.8% had Solid organ tumors, (44.0%) Hematological malignancy, and (50.0%) lymphoma, with no significant difference (p=0.755). Age was a significant predictor of IgG positivity (p= 0.018, OR= 1.034), while gender showed no- association. Although the prevalence of T. gondii was not significantly higher in cancer patients, the relatively high seropositivity (46.1%) is clinically important, as latent infection may reactivate during chemotherapy and cause severe outcomes, So, screening for Toxoplasmosis should receive significant attention for these patients.
Zitieren
APA
Mohammed, D. M., & Mohammed, L. O. (2026). Toxoplasma gondii Seropositivity in Chemotherapy- Treated Cancer Patients in Sulaimani Province, Iraq. Academic Journal of International University of Erbil. https://doi.org/10.63841/iue3261100
Vancouver
Mohammed DM, Mohammed LO. Toxoplasma gondii Seropositivity in Chemotherapy- Treated Cancer Patients in Sulaimani Province, Iraq. Academic Journal of International University of Erbil. 2026. doi:10.63841/iue3261100
BibTeX
@article{Mohammed2026,
author = {Mohammed, Drakhshan Mahmood and Mohammed, Latif Omer},
title = {Toxoplasma gondii Seropositivity in Chemotherapy- Treated Cancer Patients in Sulaimani Province, Iraq},
journal = {Academic Journal of International University of Erbil},
year = {2026},
doi = {10.63841/iue3261100}
}
EUVIMED